Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?
Author:
Affiliation:
1. Institut Necker-Enfants MaladesParis, France
2. Hôpital Necker-Enfants MaladesParis, France
3. Hôpital DupuytrenLimoges, France
4. Hôpital BretonneauTours, Franceand
5. Université Paris SorbonneParis, France
Publisher
American Thoracic Society
Subject
Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Link
https://www.atsjournals.org/doi/pdf/10.1164/rccm.201808-1436LE
Reference6 articles.
1. Cystic fibrosis
2. Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data
3. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
4. Pranke I, Veit G, Golec A, Hatton AN, Guyen T, Kyrilli S, et al. May the primary human nasal epithelial cell cultures be considered as a biomarker to predict the clinical efficacy of CFTR modulators? Presented at the 15th European Cystic Fibrosis Society Basic Science Conference. March 21–24, 2018, Loutraki, Greece. Abstract 127.
5. Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells;Respiratory Research;2024-07-10
2. In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis;Journal of Cystic Fibrosis;2024-07
3. Cystic fibrosis cell models for high-throughput analysis and drug screening;Journal of Cystic Fibrosis;2024-07
4. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells;Cell Reports Medicine;2024-05
5. Unmet challenges in cystic fibrosis treatment with modulators;Expert Review of Respiratory Medicine;2024-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3